Publications by authors named "K Zeman"

Study Question: What are the factors influencing the decline in the birth rates observed in higher-income countries in the later phase of the COVID-19 pandemic?

Summary Answer: Our results suggest that economic uncertainty, non-pharmaceutical policy interventions, and the first wave of the population-wide vaccination campaign were associated with the decline in birth rates during 2022.

What Is Known Already: During the COVID-19 pandemic, birth rates in most higher-income countries first briefly declined and then shortly recovered, showing no common trends afterwards until early 2022, when they unexpectedly dropped.

Study Design Size Duration: This study uses population-wide data on monthly total fertility rates (TFRs) adjusted for seasonality and calendar effects provided in the Human Fertility Database (HFD).

View Article and Find Full Text PDF

Shunt infection is one of the most common complications of conventional hydrocephalus treatment. The route of invasion of a pathogen can modify the immune response of the CNS. The aim of the study is to analyze the immune response to shunt infection caused by S.

View Article and Find Full Text PDF

Recent studies show e-cigarette (EC) users have increased rates of chronic bronchitic symptoms that may be associated with depressed mucociliary clearance (MCC). Little is known about the acute or chronic effects of EC inhalation on MCC. MCC was measured in young adult vapers ( = 5 males, mean age = 21) after controlled inhalation of a radiolabeled (Tc99m sulfur colloid) aerosol.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates disparities in cancer clinical trial (CT) enrollment at a major Canadian cancer center, revealing that overall enrollment was quite low at 11.2%.
  • It identifies significant barriers to participation, particularly for women, older adults (≥65 years), non-English speakers, and those living far from the center (≥250 km).
  • The results highlight a pressing need for targeted strategies to enhance access and diversity in cancer clinical trials across Canada.
View Article and Find Full Text PDF